Deriving risks of Down's syndrome from nuchal translucency measurements

被引:5
作者
Crossley, JA [1 ]
Aitken, DA [1 ]
机构
[1] Inst Med Genet, Glasgow, Lanark, Scotland
关键词
D O I
10.1046/j.1469-0705.1999.14060438.x
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
引用
收藏
页码:438 / 438
页数:1
相关论文
共 4 条
[1]   Screening for Down's syndrome: Changes in marker levels and detection rates between first and second trimesters [J].
Berry, E ;
Aitken, DA ;
Crossley, JA ;
Macri, JN ;
Connor, JM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (07) :811-817
[2]   ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL [J].
CUCKLE, HS ;
WALD, NJ ;
THOMPSON, SG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05) :387-402
[3]   UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation [J].
Snijders, RJM ;
Noble, P ;
Sebire, N ;
Souka, A ;
Nicolaides, KH .
LANCET, 1998, 352 (9125) :343-346
[4]   A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A [J].
Spencer, K ;
Souter, V ;
Tul, N ;
Snijders, R ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 13 (04) :231-237